14-90644198-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001010854.2(TTC7B):c.1601C>G(p.Ala534Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000486 in 1,441,288 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010854.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC7B | NM_001010854.2 | c.1601C>G | p.Ala534Gly | missense_variant | Exon 15 of 20 | ENST00000328459.11 | NP_001010854.1 | |
TTC7B | NM_001401365.1 | c.1601C>G | p.Ala534Gly | missense_variant | Exon 15 of 22 | NP_001388294.1 | ||
TTC7B | NM_001320421.2 | c.1295C>G | p.Ala432Gly | missense_variant | Exon 15 of 21 | NP_001307350.1 | ||
TTC7B-AS1 | NR_110134.1 | n.103-546G>C | intron_variant | Intron 1 of 4 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 0.00000486 AC: 7AN: 1441288Hom.: 0 Cov.: 32 AF XY: 0.00000419 AC XY: 3AN XY: 716644
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1601C>G (p.A534G) alteration is located in exon 15 (coding exon 15) of the TTC7B gene. This alteration results from a C to G substitution at nucleotide position 1601, causing the alanine (A) at amino acid position 534 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.